Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial.
Schwameis, Michael
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. [electronic resource] - The Lancet. Infectious diseases 09 2016 - 1036-1044 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-4457
10.1016/S1473-3099(16)30115-3 doi
Adjuvants, Immunologic--administration & dosage
Adolescent
Adult
Bacterial Toxins--isolation & purification
Double-Blind Method
Enterotoxins--isolation & purification
Female
Healthy Volunteers
Humans
Immunization Schedule
Immunization, Secondary--methods
Male
Middle Aged
Shock, Septic--prevention & control
Superantigens--isolation & purification
Vaccination
Vaccines, Synthetic--administration & dosage
Young Adult
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. [electronic resource] - The Lancet. Infectious diseases 09 2016 - 1036-1044 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-4457
10.1016/S1473-3099(16)30115-3 doi
Adjuvants, Immunologic--administration & dosage
Adolescent
Adult
Bacterial Toxins--isolation & purification
Double-Blind Method
Enterotoxins--isolation & purification
Female
Healthy Volunteers
Humans
Immunization Schedule
Immunization, Secondary--methods
Male
Middle Aged
Shock, Septic--prevention & control
Superantigens--isolation & purification
Vaccination
Vaccines, Synthetic--administration & dosage
Young Adult